Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 22

1.

Adapting Cord Blood Collection and Banking Standard Operating Procedures for HLA-Homozygous Induced Pluripotent Stem Cells Production and Banking for Clinical Application.

Alvarez-Palomo B, Vives J, Casaroli-Marano RPP, G Gomez SG, Rodriguez Gómez L, Edel MJ, Querol Giner S.

J Clin Med. 2019 Apr 8;8(4). pii: E476. doi: 10.3390/jcm8040476. Review.

2.

iPS-Cell Technology and the Problem of Genetic Instability-Can It Ever Be Safe for Clinical Use?

Attwood SW, Edel MJ.

J Clin Med. 2019 Feb 28;8(3). pii: E288. doi: 10.3390/jcm8030288. Review.

3.

Global Proteomic and Methylome Analysis in Human Induced Pluripotent Stem Cells Reveals Overexpression of a Human TLR3 Affecting Proper Innate Immune Response Signaling.

Requena J, Alvarez-Palomo AB, Codina-Pascual M, Delgado-Morales R, Moran S, Esteller M, Sal M, Juan M, Boronat Barado A, Consiglio A, Bogle OA, Wolvetang E, Ovchinnikov D, Alvarez I, Jaraquemada D, Mezquita-Pla J, Oliva R, Edel MJ.

Stem Cells. 2019 Apr;37(4):476-488. doi: 10.1002/stem.2966. Epub 2019 Feb 14.

4.

Helios expression coordinates the development of a subset of striatopallidal medium spiny neurons.

Martín-Ibáñez R, Pardo M, Giralt A, Miguez A, Guardia I, Marion-Poll L, Herranz C, Esgleas M, Garcia-Díaz Barriga G, Edel MJ, Vicario-Abejón C, Alberch J, Girault JA, Chan S, Kastner P, Canals JM.

Development. 2017 Apr 15;144(8):1566-1577. doi: 10.1242/dev.138248. Epub 2017 Mar 13.

5.

Effects of the Post-Spinal Cord Injury Microenvironment on the Differentiation Capacity of Human Neural Stem Cells Derived from Induced Pluripotent Stem Cells.

López-Serrano C, Torres-Espín A, Hernández J, Alvarez-Palomo AB, Requena J, Gasull X, Edel MJ, Navarro X.

Cell Transplant. 2016 Oct;25(10):1833-1852. doi: 10.3727/096368916X691312.

6.

The Possible Future Roles for iPSC-Derived Therapy for Autoimmune Diseases.

Hew M, O'Connor K, Edel MJ, Lucas M.

J Clin Med. 2015 May 28;4(6):1193-206. doi: 10.3390/jcm4061193. Review.

7.

Bioengineering and Stem Cell Technology in the Treatment of Congenital Heart Disease.

Bosman A, Edel MJ, Blue G, Dilley RJ, Harvey RP, Winlaw DS.

J Clin Med. 2015 Apr 22;4(4):768-81. doi: 10.3390/jcm4040768. Review.

8.

Myogenic Precursors from iPS Cells for Skeletal Muscle Cell Replacement Therapy.

Roca I, Requena J, Edel MJ, Alvarez-Palomo AB.

J Clin Med. 2015 Jan 29;4(2):243-59. doi: 10.3390/jcm4020243. Review.

9.

Prospects for clinical use of reprogrammed cells for autologous treatment of macular degeneration.

Alvarez Palomo AB, McLenachan S, Chen FK, Da Cruz L, Dilley RJ, Requena J, Lucas M, Lucas A, Drukker M, Edel MJ.

Fibrogenesis Tissue Repair. 2015 May 15;8:9. doi: 10.1186/s13069-015-0026-9. eCollection 2015.

10.

mRNA transfection of mouse and human neural stem cell cultures.

McLenachan S, Zhang D, Palomo AB, Edel MJ, Chen FK.

PLoS One. 2013 Dec 26;8(12):e83596. doi: 10.1371/journal.pone.0083596. eCollection 2013.

11.

The Power and the Promise of Cell Reprogramming: Personalized Autologous Body Organ and Cell Transplantation.

Palomo AB, Lucas M, Dilley RJ, McLenachan S, Chen FK, Requena J, Sal MF, Lucas A, Alvarez I, Jaraquemada D, Edel MJ.

J Clin Med. 2014 Apr 4;3(2):373-87. doi: 10.3390/jcm3020373. Review.

12.

Plant hormones increase efficiency of reprogramming mouse somatic cells to induced pluripotent stem cells and reduce tumorigenicity.

Alvarez Palomo AB, McLenachan S, Requena Osete J, Menchón C, Barrot C, Chen F, Munné-Bosch S, Edel MJ.

Stem Cells Dev. 2014 Mar 15;23(6):586-93. doi: 10.1089/scd.2013.0292. Epub 2014 Jan 7.

13.

Cyclin A1 is essential for setting the pluripotent state and reducing tumorigenicity of induced pluripotent stem cells.

McLenachan S, Menchón C, Raya A, Consiglio A, Edel MJ.

Stem Cells Dev. 2012 Oct 10;21(15):2891-9. doi: 10.1089/scd.2012.0190. Epub 2012 Jun 25.

14.

A protocol to assess cell cycle and apoptosis in human and mouse pluripotent cells.

Edel MJ, Menchon C, Vaquero JM, Izpisua Belmonte JC.

Cell Commun Signal. 2011 Apr 11;9(1):8. doi: 10.1186/1478-811X-9-8.

15.
16.

Rem2 GTPase controls proliferation and apoptosis of neurons during embryo development.

Edel MJ, Boué S, Menchon C, Sánchez-Danés A, Izpisua Belmonte JC.

Cell Cycle. 2010 Sep 1;9(17):3414-22. Epub 2010 Sep 11.

PMID:
20729629
17.

The cell cycle and pluripotency: Is there a direct link?

Edel MJ, Izpisua Belmonte JC.

Cell Cycle. 2010 Jul 15;9(14):2694-5. No abstract available.

PMID:
20581443
18.

Rem2 GTPase maintains survival of human embryonic stem cells as well as enhancing reprogramming by regulating p53 and cyclin D1.

Edel MJ, Menchon C, Menendez S, Consiglio A, Raya A, Izpisua Belmonte JC.

Genes Dev. 2010 Mar 15;24(6):561-73. doi: 10.1101/gad.1876710.

20.

Integrin Cytoplasmic domain-Associated Protein-1 (ICAP-1) promotes migration of myoblasts and affects focal adhesions.

Alvarez B, Stroeken PJ, Edel MJ, Roos E.

J Cell Physiol. 2008 Feb;214(2):474-82.

PMID:
17654484

Supplemental Content

Loading ...
Support Center